Agendia
PrivateLast Round
Debt
May 1, 2020
Total Funding Raised
$154.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Agendia is a precision oncology company that provides genomic diagnostic and information solutions to aid physicians in making optimized decisions for breast cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agendia Comparables
Compare Agendia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreludeDx | 88% | |
| Hologic, Inc. | 83% | |
| Veracyte | 81% |
Agendia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 1, 2020 | ||||
| VC Round | Jul 25, 2018 | ||||
| Grant | Dec 16, 2015 | ||||
| Debt | Mar 14, 2014 | ||||
| Private Equity | May 31, 2012 | ||||
Series E | Sep 22, 2009 |
Key People
Founding team and executive leadership
Agendia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norgine Ventures | Debt |
| Gilde Investment Management | Series A |
| Korys | Private Equity |
| European Commission | Grant |
| ING Corporate Investments | Series E, Private Equity, Series D |
| Gilde Healthcare | Series D, Series E, Private Equity, Series C, Series A |
| The Van Herk Group | Series A, Series E, Private Equity, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 32% MoM.
- Jan 20, 2026
MammaPrint test recognized in updated NCCN guidelines for breast cancer treatment.
Agendia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Agendia's valuation, stock price, and market status.
Is Agendia a public or private company?
Agendia is a private company.
What is the current stock price of Agendia?
Agendia is a private company, so its shares have no public market price. Caplight tracks Agendia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Agendia worth (valuation)?
Valuation information for Agendia is not publicly available.
Can I buy Agendia stock?
Agendia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Agendia's last funding round?
Agendia's most recent funding round was Debt on May 1, 2020.
Who are the main investors in Agendia?
Key investors in Agendia include Norgine Ventures, Gilde Investment Management, ING Corporate Investments, Gilde Healthcare, Athyrium Capital Management.
Will Agendia IPO soon?
No public IPO plans have been announced for Agendia.
How can I track Agendia secondary market activity?
Caplight tracks bids, offers, and trades in Agendia's shares on secondary markets.